• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sakar Healthcare Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 66415.0
  • ISIN : INE732S01012
362.65 -6 (-1.53%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    352.15

  • Today’s High

    375.00

  • Open

    361.20

  • Perv Close

    368.30

  • 52W Low

    210.10

  • 52W High

    380.80

Key Indicators

  • P/E(TTM)

    40.21

  • Mar.Cap (₹Cr.)

    796.01

  • Div & Yield %

    0.00

  • Book Value(₹)

    130.10

  • Debt-Equity Ratio

    -1.53

  • AGM Date

    25-Jul-2025

  • EPS

    9.02

  • P/E Ratio

    40.21

Financials Ratios

  • Debt-Equity Ratio

    0.46

  • Mar.Cap (₹Cr.)

    796.01

  • RONW (%)

    5.36

  • ROCE (%)

    7.36

Score Board

  • Equity (₹ in Cr.)

    21.95

  • BV (₹)

    130.10

  • Sales( ₹ in Cr.)

    177.58

  • NP (in Cr.)

    17.54

  • NP Var(%)

    52.0

  • Div%

    0.0

  • CPS (₹)

    17.50

  • EPS (₹)

    8.00

  • Traded Value (₹ in Lakhs)

    796.01

  • 52 Week High

    380.80

  • 52 Week Low

    210.10

  • Price BSE

    0.0

  • Price NSE

    363.00

  • Market Capital( in Cr.)

    796.01

  • P/C Ratio

    20.70

  • P/E Ratio

    45.40

  • Price Vs.BV

    8.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 153.35 133.36 128.23 94.74 82.98 68.25
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 153.35 133.36 128.23 94.74 82.98 68.25
Other Income 3.18 4.67 2.17 1.18 2.02 0.68
Stock Adjustments 1.38 0.36 -0.93 0.91 -0.15 -0.11
Total Income 157.91 138.39 129.47 96.83 84.85 68.82
EXPENDITURE :            
Raw Materials 85.05 74.00 73.69 52.20 43.00 35.57
Power and Fuel Cost 4.25 2.90 3.01 2.26 3.31 3.23
Employee Cost 18.82 15.81 14.26 12.74 11.61 8.45
Other Manufacturing Expenses 0.74 0.69 0.95 0.90 0.89 0.71
Selling and Administration Expenses 6.92 6.85 5.70 4.11 4.38 3.23
Miscellaneous Expenses 0.57 0.34 0.28 0.84 0.09 0.09
Employee Benefit Expenses 18.82 15.81 14.26 12.74 11.61 8.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 116.36 100.58 97.89 73.04 63.28 51.28
Operating Profit 41.54 37.81 31.58 23.78 21.57 17.54
Interest 7.59 5.95 2.90 2.48 2.26 2.27
Gross Profit 33.95 31.86 28.68 21.30 19.31 15.27
Depreciation 18.05 14.99 9.67 8.06 7.08 6.04
Profit Before Tax 15.90 16.87 19.01 13.24 12.23 9.23
Current Tax 0.00 0.00 3.41 3.18 2.63 2.59
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.23 4.12 0.35 -0.63 -0.03 -0.05
Reported Net Profit 11.67 12.76 15.24 10.69 9.62 6.69
Extraordinary Items 0.17 0.07 0.03 -0.11 -0.04 -0.04
Adjusted Net Profit 11.50 12.69 15.21 10.80 9.66 6.73
Adjustment below Net Profit 0.00 0.00 0.00 -0.75 0.00 -0.01
P & L Balance brought forward 68.95 56.19 40.95 31.00 21.38 14.69
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 80.62 68.95 56.19 40.95 31.00 21.38
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.37 6.70 8.90 6.85 6.43 4.47
Earnings Per Share(Adj)-Unit Curr 5.37 6.70 8.90 6.85 6.43 4.47
Book Value 118.44 91.09 74.50 63.04 54.35 47.95
Book Value(Adj)-Unit Curr 118.44 91.09 74.50 63.04 54.35 47.95

Shareholding Pattern

  • Promoter Group

    53.58%

  • Public Share Holding

    46.42%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,761,043 53.58 11,761,043 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,761,043 53.58 11,761,043 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,986,362 13.61 2,986,362 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,407,397 10.97 2,407,397 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,393,759 24.57 5,393,759 7
2] Non Institution
Bodies Corporate 985,843 4.49 985,843 55
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 96,199 0.44 96,199 125
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 165,608 0.75 165,608 209
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 739,800 3.37 739,800 16
Individuals holding nominal share capital up to Rs. 1 lakh 2,757,924 12.56 2,757,924 8,181
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2 0.00 2 1
Sub Total 4,795,108 21.85 4,795,108 8,597
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,949,910 100.00 21,949,910 8,608

Company Background

Sakar Healthcare LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sakar Healthcare Ltd
  • BSE Code : 66415.0
  • ISIN : INE732S01012

  • Incorporation Year

    2004

  • Registered Office

    10/13 Nr MN Desai Petrol Pump
    Sarkhej Bavla Highway, Changodar,
    Gujarat-382213

  • Telephone

    91-2717-250477

  • FAX

    91-2717-251621

  • Chairman

    Sanjay S Shah.

  • Managing Director

    Sanjay S Shah.

  • Company Secretary

    Bharat Soni

  • Auditor

    J S Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Sakar Healthcare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sakar Healthcare 362.65 156.53 153.35 40.29 7.36
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10